Aberrant NMDA receptor DNA methylation detected by epigenome-wide analysis of hippocampus and prefrontal cortex in major depression
The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Current perspectives on the molecular underpinnings of major depressive disorder (MDD) posit a mechanistic role of epigenetic DNA modifications in mediating the interaction between environmental risk factors and a genetic predisposition. However, conclusive evidence for differential methylation signatures in the brain's epigenome of MDD patients as compared to controls is still lacking. To address this issue, we conducted a pilot study including an epigenome-wide methylation analysis in six individuals diagnosed with recurrent MDD and six control subjects matched for age and gender, with a priori focus on the hippocampus and prefrontal cortex as pathophysiologically relevant candidate regions. Our analysis revealed differential methylation profiles of 11 genes in hippocampus and 20 genes in prefrontal cortex, five of which were selected for replication of the methylation status using pyrosequencing. Among these replicated targets, GRIN2A was found to be hypermethylated in both prefrontal cortex and hippocampus. This finding may be of particular functional relevance as GRIN2A encodes the glutamatergic N-methyl-D-aspartate receptor subunit epsilon-1 (NR2A) and is known to be involved in a plethora of synaptic plasticity-related regulatory processes probably disturbed in MDD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Twenty genes are found to be differentially methylated in PFC of MDD patients from a genome-wide methylation analysis, including hypermethylation of Grin2a 232.”
From Mechanisms of synaptic transmission dysregulation in the prefrontal cortex: pathophysiological implications (2022) · cites this paper as [232]
Citations
Cites
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
Antidepressant effects of ketamine in depressed patients
Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00230-9 · Cited by 3,856
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Zarate, C. A., Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.856 · Cited by 3,766
The molecular neurobiology of depression
Krishnan, V., & Nestler, E. J. (2008) · Nature · doi:10.1038/nature07455 · Cited by 2,889
mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
Li, N., Lee, B., Liu, R.-J., Banasr, M., Dwyer, J. M., Iwata, M., Li, X.-Y., Aghajanian, G., & Duman, R. S. (2010) · Science · doi:10.1126/science.1190287 · Cited by 2,881
NMDA receptor subunits: diversity, development and disease
Cull-Candy, S., Brickley, S., & Farrant, M. (2001) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(00)00215-4 · Cited by 1,694
Synaptic Dysfunction in Depression: Potential Therapeutic Targets
Duman, R. S., & Aghajanian, G. K. (2012) · Science · doi:10.1126/science.1222939 · Cited by 1,651
Millan, M. J., Agid, Y., Brüne, M., Bullmore, E. T., Carter, C. S., Clayton, N. S., Connor, R., Davis, S., Deakin, B., DeRubeis, R. J., et al. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3628 · Cited by 1,292
Murrough, J. W., Iosifescu, D. V., Chang, L. C., Al Jurdi, R. K., Green, C. E., Perez, A. M., Iqbal, S., Pillemer, S., Foulkes, A., Shah, A., et al. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.13030392 · Cited by 1,205
Epigenetics and gene expression
Gibney, E. R., & Nolan, C. M. (2010) · Heredity · doi:10.1038/hdy.2010.54 · Cited by 1,109
Cited by
The Role of Neural Plasticity in Depression: From Hippocampus to Prefrontal Cortex
Liu, W., Ge, T., Leng, Y., Pan, Z., Fan, J., Yang, W., & Cui, R. (2017) · Neural Plasticity · doi:10.1155/2017/6871089 · Cited by 640
“The GRIN2A gene, which encodes the glutamatergic N-methyl-D-aspartate (NMDA) receptor subunit epsilon-1 in the prefrontal cortex, is probably disturbed in the regulation of synaptic plasticity in depression [69].”
BackgroundYan, Z., & Rein, B. (2022) · Molecular Psychiatry · doi:10.1038/s41380-021-01092-3 · Cited by 300
“In addition to the involvement of PFC synaptic dysregulation in depression, epigenetic changes have been described in the PFC of individuals with MDD. Twenty genes are found to be differentially methylated in PFC of MDD patients from a genome-wide methylation analysis, including hypermethylation of Grin2a [232].”
BackgroundYuan, M., Yang, B., Rothschild, G., Mann, J. J., Sanford, L. D., Tang, X., Huang, C., Wang, C., & Zhang, W. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01519-z · Cited by 246
“88 94 – 97 Another study comparing DNA methylation across the whole genome in live human brain tissue with that in peripheral (blood, saliva, and buccal) tissues concluded that the patterns unique to the target genomic region must be considered when selecting the best surrogate tissue to mimic…”
BackgroundBrain NMDA Receptors in Schizophrenia and Depression
Adell, A. (2020) · Biomolecules · doi:10.3390/biom10060947 · Cited by 212
A review of DNA methylation in depression
Chen, D., Meng, L., Pei, F., Zheng, Y., & Leng, J. (2017) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2017.05.022 · Cited by 171
Rizzardi, L. F., Hickey, P. F., Rodriguez DiBlasi, V., Tryggvadóttir, R., Callahan, C. M., Idrizi, A., Hansen, K. D., & Feinberg, A. P. (2019) · Nature Neuroscience · doi:10.1038/s41593-018-0297-8 · Cited by 146
Synaptic GluN2A-Containing NMDA Receptors: From Physiology to Pathological Synaptic Plasticity
Franchini, L., Carrano, N., Luca, M. D., & Gardoni, F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041538 · Cited by 135
What do DNA methylation studies tell us about depression? A systematic review
Li, M., D’Arcy, C., Li, X., Zhang, T., Joober, R., & Meng, X. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0412-y · Cited by 125
The receptor hypothesis and the pathogenesis of depression: Genetic bases and biological correlates
Wang, H., Wang, Z., & Chen, N. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105542 · Cited by 126
NMDA receptor hypofunction for schizophrenia revisited: Perspectives from epigenetic mechanisms
Snyder, M. A., & Gao, W. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.03.010 · Cited by 102
“GRIN2A increase DNA hypermethylation Gene expression OTX2, LYNX1, GPR (Kaut et al., 2015)”
BackgroundInfluentialHumphreys, K. L., Moore, S. R., Davis, E., MacIsaac, J. L., Lin, D. T. S., Kobor, M. S., & Gotlib, I. H. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0582-7 · Cited by 71
Grassi, D., Franz, H., Vezzali, R., Bovio, P., Heidrich, S., Dehghanian, F., Lagunas, N., Belzung, C., Krieglstein, K., & Vogel, T. (2017) · Cerebral Cortex · doi:10.1093/cercor/bhx095 · Cited by 57
“Alteration of DNA methylation has also been observed in different pathological conditions, including mood disorders such as depression (Córdova-Palomera et al. 2015; Haghighi et al. 2015; Kaut et al. 2015; Le François et al. 2015; Nemoda et al. 2015; Walker et al. 2016), in which neuronal activity is also altered (Yao…”
BackgroundViuff, A. F., Sharp, G. C., Rai, D., Henriksen, T. B., Pedersen, L. H., Kyng, K. J., Staunstrup, N. H., Hidalgo, A. P. C., Neumann, A., Felix, J. F., et al. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0286-4 · Cited by 63
NMDA Receptors: Distribution, Role, and Insights into Neuropsychiatric Disorders
Beaurain, M., Salabert, A., Payoux, P., Gras, E., & Talmont, F. (2024) · Pharmaceuticals · doi:10.3390/ph17101265 · Cited by 60
“In some depressive patients, abnormalities in the expression of genes encoding the receptor have been detected [159,160].”
BackgroundLu, W., Yang, X., Zhong, W., Chen, G., Guo, X., Ye, Q., Xu, Y., Qi, Z., Ye, Y., Zhang, J., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci174847 · Cited by 57
“Aberrant GRIN2A hypermethylation has been found in the hippocampus and prefrontal cortex in major depressive disorder (42).”
Topham, L., Grégoire, S., Kang, H., Salmon‐Divon, M., Lax, E., Millecamps, M., Szyf, M., & Stone, L. S. (2020) · Pain · doi:10.1097/j.pain.0000000000001917 · Cited by 52
“This is a robust shift in methylation state for most DMCpG positions and is on par with that observed in the brain for major depressive disorder.(31)”
ResultLawford‐Smith, H. (2015) · Journal of Social Ontology · doi:10.1515/jso-2015-0008 · Cited by 60
Sun, Y., Cheng, X., Zhang, L., Hu, J. H., chen, Y., Zhan, L., & Gao, Z. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9715-7 · Cited by 43
Guo, Y., Cai, H., Chen, L., Liang, D., Yang, R., Dang, R., & Jiang, P. (2016) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2016.04.006 · Cited by 33
“In line with these findings, disturbed glutamatergic and GABAergic neurotransmission also have been observed in the postmortem brain of depression patients and in the brain tissues of animal models of depression (Abdallah et al., 2015, Kaut et al., 2015).”
Okada, M., Kawano, Y., Fukuyama, K., Motomura, E., & Shiroyama, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21217951 · Cited by 32
“Epigenetic studies found hypermethylation of gene bodies of GluN1 and GluN2A in depression [50,51].”
BackgroundWeinstein-Fudim, L., Ergaz, Z., Turgeman, G., Yanai, J., Szyf, M., & Ornoy, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215278 · Cited by 27
“Up regulation of GRIN2A receptor was also found in the prefrontal cortex of patients with major depression [103,104].”
BackgroundTargeting NMDA Receptors in Emotional Disorders: Their Role in Neuroprotection
Wang, S., Bian, L.-H., Yin, Y., & Guo, J. (2022) · Brain Sciences · doi:10.3390/brainsci12101329 · Cited by 39
Genetic variant in CACNA1C is associated with PTSD in traumatized police officers
Krzyzewska, I. M., Ensink, J. B. M., Nawijn, L., Mul, A. N. P. M., Koch, S. B. J., Venema, A., Shankar, V., Frijling, J. L., Veltman, D. J., Lindauer, R., et al. (2018) · European Journal of Human Genetics · doi:10.1038/s41431-017-0059-1 · Cited by 33
“Interestingly, the SDK1 gene has been implicated in schizophrenia [48] and autism [49], and altered SDK1 methylation was observed in post-mortem brain tissue of MDD patients [47].”
BackgroundSales, A. J., Maciel, I. D. S., Suavinha, A. C. D. R., & Joca, S. R. L. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02145-4 · Cited by 31
Kiese, K., Jablonski, J., Hackenbracht, J., Wrosch, J. K., Groemer, T. W., Kornhuber, J., Blümcke, I., & Kobow, K. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0485-x · Cited by 29
“Moreover, aberrant DNA methylation at the GRIN2A locus was described in patients with major depression [31].”
How could N-Methyl-D-Aspartate Receptor Antagonists Lead to Excitation Instead of Inhibition?
Su, T., Lu, Y., Geng, Y., Lü, W., & Chen, Y. (2018) · Brain Science Advances · doi:10.26599/bsa.2018.2018.9050009 · Cited by 28
“Hypermethylation of the GRIN2A gene has been observed by epigenome‐ wide methylation analysis in human brain specimens [163].”
BackgroundLi, Z., Wang, G., Zhong, S., Liao, X., Lai, S., Shan, Y., Chen, J., Zhang, L., Lu, Q., Shen, S., et al. (2020) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2020.152200 · Cited by 27
Epigenetic Alterations of Brain Non-Neuronal Cells in Major Mental Diseases
Abdolmaleky, H. M., Martin, M., Zhou, J., & Thiagalingam, S. (2023) · Genes · doi:10.3390/genes14040896 · Cited by 25
“GRIN2A Astrocytes Aβ cleanup Depression ? DNA hypermethylation [76]”
BackgroundPoletti, S., Locatelli, C., Falini, A., Colombo, C., & Benedetti, F. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2016.07.007 · Cited by 24
“Supporting this hypothesis, recent data showed that DNA methylation of genes that encode NMDA subunits are affected by early stress (Weder et al., 2014) and depression (Kaut et al., 2015) thus suggesting epigenetic mechanisms as possible pathway leading to altered glutamate levels.”
ResultSaez, E., Erkoreka, L., Moreno-Calle, T., Berjano, B., González-Pinto, A. M., Basterreche, N., & Arrúe, A. (2022) · World Journal of Psychiatry · doi:10.5498/wjp.v12.i7.884 · Cited by 22
Saito, T., Whatmore, P., Taylor, J. F., Fernandes, J. M. O., Adam, A., Tocher, D. R., Espe, M., & Skjærven, K. H. (2022) · BMC Genomics · doi:10.1186/s12864-022-08348-4 · Cited by 20
“The precise epigenetic regulation of GRIN3A is unknown, but DNA methylation in the promoter of glutamate ionotropic receptor NMDA type subunit 2a (GRIN2A), which is another subunit of NMDA, is strongly associated with major depressive disorder in humans [38].”
BackgroundFilippone, A., Cucinotta, L., Bova, V., Lanza, M., Casili, G., Paterniti, I., Campolo, M., Cuzzocrea, S., & Esposito, E. (2023) · Cells · doi:10.3390/cells12071040 · Cited by 20
“…that elevated concentrations of free Cu in serum are associated with cognitive deficits, neurodegenerative diseases Cells 2023 , 12 , 1040 2 of 18 such as Alzheimer’s disease (AD) [7] and changes in the glutamate/N-methyl-D-aspartic acid receptor (NMDAR) in HP individuals diagnosed with MDD [8].”
BMI Modifies the Association Between Depression Symptoms and Serum Copper Levels
Wu, H., Li, Q., Gao, R., Tang, S., Kaifang, Z., & Zhao, J. (2022) · Biological Trace Element Research · doi:10.1007/s12011-022-03505-y · Cited by 19
Flynn, L. T., & Gao, W. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02235-4 · Cited by 19
“GRIN2A hypermethylation has also been identi fi ed in the PFC and hippocampus of depressed individuals compared to healthy controls examination of post-mortem brain tissue [174].”
Itaconate: A promising precursor for treatment of neuroinflammation associated depression
Liu, R., Gong, Y., Xia, C., Cao, Y., Zhao, C., & Zhou, M. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115521 · Cited by 21
Yates, J. R. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.111107 · Cited by 16
Donello, J. E., McIntyre, R. S., Pickel, D. B., & Stahl, S. M. (2025) · Pharmaceuticals · doi:10.3390/ph18020157 · Cited by 15
“Abnormalities in NMDAR genes are associated with depression, including treatment-resistant depression [44–47].”
Musazzi, L., Paoli, C., Misztak, P., & Mazzini, G. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666220201084536 · Cited by 18
“However, two epigenome-wide association studies (EWASs) on MDD obtained interesting results regarding methylation levels of genes encoding NMDA subunits 1 ( GRIN1 ) and 2A ( GRIN2A ) [110, 136].”
Cao, K., Zhong, J., Wang, S., Shi, Y., Bai, S., Zhao, J., Yang, L., Liang, Q., Deng, D., & Zhang, R. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.118040 · Cited by 15
Famitafreshi, H., & Karimian, M. (2019) · Acta Neurobiologiae Experimentalis · doi:10.21307/ane-2019-016 · Cited by 15
“Mechanisms underlying depression based on previous studies include methylation of NMDA receptors in pre‑ frontal cortex and hippocampus (Kaut et al., 2015).”
BackgroundBrain and Blood Biomarkers of Major Depressive Disorder: A Systematic Review
Zallar, L. J., & Dupont, M. B. (2026) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2025.4613 · Cited by 16
Rastad, S., Barjaste, N., Lanjanian, H., Moeini, A., Anka, F., & Masoudi‐Nejad, A. (2022) · Genes & Genetic Systems · doi:10.1266/ggs.22-00022 · Cited by 12
Kaut, O., Sharma, A., Schmitt, I., Hurlemann, R., & Wüllner, U. (2017) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2017.05.030 · Cited by 13
“Detail description of patient samples has been given in Kaut et al., 2015 [26].”
Self-citationZhang, J., Duan, J., Li, W., Wang, X., Ren, S., Ye, L., Liu, F., Tian, X., Xie, Y., Huang, Y., et al. (2025) · Science Advances · doi:10.1126/sciadv.adq0444 · Cited by 14
“Aberrant gene expression and dysfunction of NMDARs in the PFC have been found in patients with MDD ( 54 – 56 ).”
Ren, H., Yu, X., Yu, L., Zhang, Y., Xie, H., Shi, N., & Chen, L. (2017) · Medical Science Monitor · doi:10.12659/msm.906781 · Cited by 11
“confirmed that NR2A is closely associated with severe depression by NMDA receptor methylation detection and related analysis [20].”
BackgroundNMDAR (2C) deletion in astrocytes relieved LPS-induced neuroinflammation and depression
Gao, R., Ali, T., Liu, Z., Li, A., He, K., Yang, C., Feng, J., & Li, S. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.111964 · Cited by 10
Barakat, A. K., Scholl, C., Steffens, M., Brandenburg, K., Ising, M., Lucae, S., Holsboer, F., Laje, G., Kalayda, G. V., Jaehde, U., et al. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-00900-8 · Cited by 10
Loureiro, C. M., Fachim, H., Zuelli, F. M. D. G. C., Shuhama, R., Menezes, P. R., Dalton, C., Del‐Ben, C. M., Reynolds, G. P., & Louzada‐Júnior, P. (2021) · Epigenomics · doi:10.2217/epi-2020-0451 · Cited by 10
Epigenetic Drugs for Mood Disorders
Peedicayil, J., & Kumar, A. (2018) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2018.01.005 · Cited by 8
Hein, S. D., Thomas, T., Naumova, O. Y., Luthar, S. S., & Grigorenko, E. L. (2018) · Developmental Psychobiology · doi:10.1002/dev.21789 · Cited by 8
Fatty acid binding proteins and their involvement in anxiety and mood disorders
Jones, M., Uzuneser, T. C., & Laviolette, S. R. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.106952 · Cited by 6
“Importantly, NMDA receptor-mediated synaptic plasticity influences how the brain processes and adapts to stress, and disruptions in NMDA receptor function can lead to maladaptive neural changes that contribute towards neuropsychiatric phenotypes (Kaut et al., 2015; McGrath et al., 2022).”
Ping, A., Yang, M., Xu, S., Li, Q., Feng, Y., Gao, K., Wang, S., & Duan, K. (2023) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2023.111210 · Cited by 7
Scherbaum, U. B. N. (2014) · Journal of Alcoholism and Drug Dependence · doi:10.4172/2329-6488.1000198 · Cited by 6
“Most recently, further evidence was found that an overexpression of NMDAreceptor subunit epsilon-1 (NR2A) might promote vulnerability for major depression [65] perhaps contributing to a tolerance in ADE [55-57].”
BackgroundResearch Progress on NMDA Receptor Enhancement Drugs for the Treatment of Depressive Disorder
Liu, R., Liu, N., Ma, L., Liu, Y., Huang, Z., Peng, X., Zhuang, C., Niu, J., Yu, J., & Du, J. (2024) · CNS Drugs · doi:10.1007/s40263-024-01123-x · Cited by 8
Classification and neurobiological concepts of mania, bipolar disorder and major depression
Schmitt, A., & Falkai, P. (2015) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-015-0599-8 · Cited by 4
“[7] investigated epigenome-wide methylation analysis in the hippocampus and prefrontal cortex of 6 patients with major depression and 6 healthy controls.”
BackgroundSrivastava, J., Yadav, J., & Dubey, N. (2026) · Cognitive Neurodynamics · doi:10.1007/s11571-026-10446-y · Cited by 3
No association of GRIN2A polymorphisms with the major depressive disorder in the Chinese Han origin
Hu, J., Bi, Y., Shi, L., Xu, F., Yuan, F., Niu, W., Ren, D., Guo, Z., Yang, F., He, L., et al. (2018) · Psychiatric Genetics · doi:10.1097/ypg.0000000000000207 · Cited by 2
The epigenetic mechanisms of ketamine in the treatment of depression: a systematic review
Leccisotti, I., Moretti, M. C., Altamura, M., Bellomo, A., Laurello, R., Carapellese, M., Sborgia, G., Dibello, V., Robert, G. H., Panza, F., et al. (2025) · Epigenomics · doi:10.1080/17501911.2025.2583892 · Cited by 2
Poydasheva, A. G., Sinitsyn, D. O., Bakulin, I. S., Suponeva, N. A., & Пирадов, М. А. (2022) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/2074-2711-2022-4-12-19 · Cited by 2
Epigenetics, stress, and depression
Lockwood, L. E., Su, S., & Youssef, N. A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823039-8.00004-6 · Cited by 1
Epigenetics of major depressive disorder
Braun, P., & Potash, J. B. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823577-5.00002-7 · Cited by 1
Simulation of nanocarrier-based targeted delivery of an antidepressant for major depressive disorder
Mehra, V., Sarkar, N., Biswal, B., & Kaushik, M. (2023) · Molecular Simulation · doi:10.1080/08927022.2023.2241764 · Cited by 2
Loureiro, C. M. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2021.tde-04082021-134444
Yuhong, W. (2021) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2021.40.006446
Deciphering the Role of Various Signaling Pathways in the Pathophysiology of Depression
Vashisht, E., Vats, V., Verma, R., Parashar, J., Garg, V., Dutt, R., Mittal, V., Singh, G., & Kaushik, D. K. (2023) · Current Signal Transduction Therapy · doi:10.2174/0115743624255521230920070219
Li, L. (2020) · eScholarship@McGill (McGill) · doi:10.82308/44525
Metadata
- Authors
- Kaut, O., Schmitt, I., Hofmann, A., Hoffmann, P., Schlaepfer, T. E., Wüllner, U., & Hurlemann, R.
- Affiliations
- University of Bonn (DE)
- German Center for Neurodegenerative Diseases (DE)
- Life & Brain (Germany) (DE)
- University of Basel (CH)
- Corresponding author
- Kaut, Oliver
- Venue
- European Archives of Psychiatry and Clinical Neuroscience
- Published
- 2015-01-09
- Volume
- 265
- Issue
- 4
- Pages
- 331-341
- ISSN
- 0003-9373 (ISSN-L)
- 0940-1334
- 1433-8491
- OpenAlex
- W2022470748
- Cited by
- 68
- References
- 46
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 6 · 2023: 8 · 2022: 9 · 2021: 6 · 2020: 7 · 2019: 6 · 2018: 7 · 2017: 7 · 2016: 3 · 2015: 2
- FWCI
- 2.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- European Archives of Psychiatry and Clinical Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- DZNE Pub (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- major depressive disorder, DNA methylation, NMDA receptor, GRIN2A, hippocampus, prefrontal cortex, epigenetics, recurrent depression, synaptic plasticity, glutamatergic signaling
- MeSH terms
- Aged, Aged, 80 and over, Major Depressive Disorder, Female, Gene Expression Regulation, Hippocampus, Humans, Male, Middle Aged, Netherlands, Postmortem Changes, Receptors, N-Methyl-D-Aspartate, Prefrontal Cortex, DNA Methylation, Epigenesis, Genetic, Microarray Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.